Skip to main content

Table 1 Demographic and clinical variables in the study subjects

From: Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life

Variable Mean (±SD) Minimum Maximum
Age (years) 36.35 ± 7.33 22.00 50.00
Duration of marriage (years) 15.07 ± 8.55 0.16 33.00
Disease duration (years) 7.37 ± 5.40 0.02 26
Age at diagnosis (years) 27.92 ± 7.57 11.00 49.50
EDSS 2.06 ± 1.85 0.00 7.50
Fatigue 3.65 ± 1.57 1.00 7.00
Anxiety 13.18(9.18) 0 20
Depression 13.46(9.57) 0 28
Stress 19.59(10.03) 0 34
QOL Physical health composite score 62.66 ± 19.15 15.42 96.24
Mental health composite score 60.75 ± 19.99 9.07 97.34
Education
N (%)
Secondary school or below 74 (24.7)
High school 132 (44.0)
University 94 (31.3)
Occupation
N (%)
Housewife 258 (86.0)
Employed 33 (11.0)
Retired 9 (3.0)
Disease pattern
N (%)
Relapsing-Remitting MS (RRMS) 243 (81.0)
Progressive MS 39 (13.0)
Clinically Isolated Syndrome (CIS) 18 (6.0)
Taking medications
N (%)
No 30 (10.0)
Yes
270 (90.0)
Disease Modifying Therapy (DMT) 141 (47.0)
Anticholinergic drugs 51 (17.0)
Psychiatric drugs 8 (2.7)
Antidepressants drugs 56(18.7)
Benzodiazepines drugs 18(6.0)
Anticonvulsants drugs 50(16.7)
   Beta blockers drugs 17 (5.7)
Antispasmodic drugs (baclofen,tizanidine, Methocarbamol) 38(12.7)
Complementary drugs 183 (61.0)